Information Library

Results for: Get to market faster - Regulatory & Quality

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Addresses Key Considerations for Successful Biosimilar Development

    Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.

  • Quintiles Names Rick Sax New Head of Integrated Clinical Services

    Press Release — May 23, 2011 – Quintiles announced the appointment of Frederic “Rick” Sax as Senior Vice President and Global Head of its Integrated Clinical Services division.rograms.

  • The US Approval Pathway for Biosimilar Products

    Hear from the Experts — February 22, 2011
    The Public Health Service Act allows biosimilars in the US. The law incorporates a specific subsection dealing with biosimilars entitled the Biologics Price Competition and Innovation Act of 2009 (BPCIA).

  • Consulting – Breakthrough Thinking Built on Experience

    Brochure — November 23, 2010
    Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today.

  • CMC, Preclinical and Clinical Considerations for Biosimilars and Follow-on Biologics

    Hear from the Experts — July 7, 2010
    This article summarizes some of the issues pertaining to biosimilars in Europe that are also likely to impact eventual FOB approval testing in the US.

  • Regulations for Clinical Studies in Pediatric Patients in the European Union

    White Paper — March 10, 2010
    After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric

  • Sub-Saharan Africa Phase II/III Fact Sheet

    Brochure — July 29, 2009
    Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.

  • Adrian McKemey, Ph.D.

    Hear from the Experts — March 25, 2009
    Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting.

  • Jim Featherstone, Ph.D.

    Hear from the Experts — March 25, 2009
    Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice.

  • Matthew Eberhart

    Hear from the Experts — March 25, 2009
    Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.

Page 1 of 2 (11 results)

Subscribe to Email Based on Your Interests

Set preferences